The odds for higher severity oral food challenge reactions did not significantly differ between patients on inhaled ...

Following the trend of other regulators, the European Medicines Agency (EMA) is taking steps to reduce the need for animal testing. The agency has issued a draft qualification opinion for a new ...

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety ...

A New York federal court partially granted a Fordham University female professor’s pro se motion to compel limited discovery in her discrimination case while finding other requests overbroad or ...

Helping patients get groceries and make meals while staying on a DASH-approved diet not only helped, but people liked it, too ...

On March 30, 2026, a federal judge in Washington, D.C. handed down a decisive win for the National Institute of Building ...

Despite randomised clinical trials (RCTs) being the gold standard for drug approval studies, the shift towards precision medicine has increased the use of single-arm trials (SATs). SATs lack results ...

Takeda Canada Inc. ("Takeda") is pleased to announce new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), ...

The Efficacy and Safety of Triple Therapy in Obstructive Lung Disease (ETHOS) and Informing the Pathway of Chronic ...

Takeda presents positive data from two pivotal phase 3 studies of zasocitinib to treat adults with moderate-to-severe plaque psoriasis at AAD meeting: Osaka, Japan Tuesday, March ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth ...

Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the 10 best penny stocks that could triple your money. On February 26, ...